HCWB HCW Biologics, Inc.: Earnings per share for the last twelve months
HCW Biologics Inc. (HCWB) maintains a stable moat based on patents targeting age-related inflammation. The 12-month rolling EPS confirms the current trend, with the latest parameter standing at -28.65. High R&D expenditures and FDA oversight create significant barriers to entry, while diversification into oncology and geriatrics via immune activation effectively minimizes scientific risks.
Analytical breakdowns and data insights for company HCW Biologics Inc (HCWB)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital HCW Biologics Inc.|HCWB - Long-Term Liabilities to Capital|Short-Term Debt to Capital HCW Biologics|HCWB - Aggregate Debt Obligations|Debts to Book Capitalization HCW Biologics|HCWB - Company Long-Term Liabilities|Company Current Liabilities HCW Biologics|Quick Liquidity Indicator hcwbiologics.com
- earnings and valuation multiples indicators:
HCWB - Final Profit|Projected Future Earnings HCW Biologics Inc.|HCWB - Price to Earnings Ratio|Forward P/E Multiple HCW Biologics, Inc.|HCWB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCW Biologics Inc.|HCWB - Profit before interest, taxes and amortization|Earnings per share for the last twelve months HCW Biologics|HCWB - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months hcwbiologics.com|HCWB - Earnings per share growth rate in current year|Earnings growth forecast for next year HCW Biologics Inc.
- sales and revenue data:
General company analysis:HCW Biologics Inc (HCWB)
The current rolling earnings per share reflects the efficiency of implementing robotic systems into the immunotherapeutic protein design of HCW Biologics Inc. (HCWB). This indicator represents the company's net income allocated per common share over the last twelve months. The calculation excludes the impact of the number of issued securities, revealing the business's actual ability to generate income. The metric's trend allows for an assessment of the return on laboratory cycle automation. The stability of this figure confirms the resilience of capitalization over the long term.
Competitor analysis
ARGX - Earnings per share for the last twelve months|BioNTech Inc. (BNTX) - Net earnings per share for the last 12 months|abivax.com (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) immunovant.com|Earnings per share for the last twelve months Kiniksa Pharmaceuticals Ltd (KNSA)|Grifols - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (adaptivebiotech.com)|Celldex (CLDX) - Net earnings per one share for the last twelve months|Aurinia Corp - Net earnings per share (EPS TTM)|BCRX: Earnings per share for the last twelve months|VERA: Net earnings per share (EPS TTM)|DNTH - Net earnings per share for the last four quarters|PHVS (Pharvaris NV) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months AbCellera Corp (ABCL)|Earnings per share for the last twelve months Tourmaline Bio, Inc. (TRML)|Net earnings per share for the last 12 months Precigen, Inc. PGEN|Earnings per share for the last twelve months Pharming Group NV PHAR|Net earnings per share (EPS TTM) Nektar Therapeutics Inc NKTR|Upstream Bio, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ZBIO (Zenas Biopharma, Inc.)|immunome.com (IMNM) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months gossamerbio.com (GOSS)|KALV (kalvista.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Septerna Corp|Net earnings per share (EPS TTM) PVLA|Savara Corp - Earnings per share for the last 12 months|Earnings per share for the last twelve months Rigel Pharmaceuticals RIGL|AnaptysBio (ANAB) - Net earnings per one share for the last twelve months|ATXS - Earnings per share for the last twelve months|ENGN (enGene) - Earnings per share for the last 12 months|RAPT: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aerovate (JBIO)|ACRS (Aclaris Therapeutics, Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) kyvernatx.com|Earnings per share for the last twelve months Tiziana Life Sciences Ltd. (TLSA)|CABA (Cabaletta Bio) - Earnings per share for the trailing year|Earnings per share for the last twelve months Ventyx Biosciences VTYX|Net earnings per share for the last four quarters Theratechnologies Inc (THTX)|avalotx.com - Net earnings per share (EPS TTM)|ELDN - Net earnings per share (EPS TTM)|AGEN (Agenus Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Climb Bio Inc.|Net earnings per share for the last 12 months ZURA|ATYR (aTyr Pharma, Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) ADAG|Net earnings per share (EPS TTM) ImageneBio (IMA)|Shattuck Labs - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) equilliumbio.com EQ|connectbiopharm.com - Net earnings per share (EPS TTM)|immunic-therapeutics.com (IMUX) - Net earnings per share for the last 12 months|ATRA: Net earnings per share (EPS TTM)|InflaRx N.V. (IFRX) - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months x4pharma.com XFOR|Net earnings per share for the last 12 months adicetbio.com (ACET)|Earnings per share for the last twelve months Celularity Inc (CELU)|Net earnings per share for the last 12 months INmune Bio Corp INMB|Earnings per share for the last twelve months barinthusbio.com BRNS|Earnings per share for the trailing year KZR|sabbiotherapeutics.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AKTX (Akari Therapeutics PLC)|ENLV: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months QTTB|GOVX (geovax.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Edesa Biotech|Net earnings per share (EPS TTM) IBIO|Net earnings per share for the last 12 months Carisma Therapeutics Inc. CARM|Earnings per share for the last twelve months XTL Biopharmaceuticals, Ltd. XTLB|Net earnings per share (EPS TTM) boltbio.com BOLT|Aptevo Therapeutics, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters aimimmuno.com AIM|ADTX (aditxt.com) - Net earnings per share for the last 12 months|GRI (GRI Bio) - Earnings per share for the last twelve months|XRTX (XORTX Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Vyome Therapeutics|Net earnings per share (EPS TTM) REVB|Net earnings per share for the last 12 months indaptusrx.com INDP|Net earnings per share (EPS TTM) SCNI (scinai.com)|Net earnings per share (EPS TTM) CalciMedica, Inc. CALI|AFMD - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Allakos Inc ALLK|HOOK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months IGM Biosciences Inc. (IGMS)|ITOS (iTeos Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ocean Biomedical Inc OCEA|Earnings per share for the last twelve months TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio, Inc) - Earnings per share for the trailing year
